59 related articles for article (PubMed ID: 27919789)
21. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
[TBL] [Abstract][Full Text] [Related]
22. The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells.
Alam F; Mezhal F; El Hasasna H; Nair VA; Aravind SR; Saber Ayad M; El-Serafi A; Abdel-Rahman WM
Tumour Biol; 2017 Sep; 39(9):1010428317714634. PubMed ID: 28933253
[TBL] [Abstract][Full Text] [Related]
23. MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
Tian X; Zhang J; Yan L; Dong JM; Guo Q
Int J Clin Exp Pathol; 2015; 8(6):6442-9. PubMed ID: 26261520
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
Guo X; Zhang J; Pang J; He S; Li G; Chong Y; Li C; Jiao Z; Zhang S; Shao M
Tumour Biol; 2016 Jul; 37(7):9181-7. PubMed ID: 26768615
[TBL] [Abstract][Full Text] [Related]
25. miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.
Liu Z; Long J; Du R; Ge C; Guo K; Xu Y
Tumour Biol; 2016 Jun; 37(6):8327-35. PubMed ID: 26729198
[TBL] [Abstract][Full Text] [Related]
26. p73 is transcriptionally regulated by DNA damage, p53, and p73.
Chen X; Zheng Y; Zhu J; Jiang J; Wang J
Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
[TBL] [Abstract][Full Text] [Related]
27. The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
Zhu J; Jiang J; Zhou W; Chen X
Cancer Res; 1998 Nov; 58(22):5061-5. PubMed ID: 9823311
[TBL] [Abstract][Full Text] [Related]
28. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
30. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
31. p73 - NAV3 axis plays a critical role in suppression of colon cancer metastasis.
Uboveja A; Satija YK; Siraj F; Sharma I; Saluja D
Oncogenesis; 2020 Feb; 9(2):12. PubMed ID: 32029709
[TBL] [Abstract][Full Text] [Related]
32. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation.
Velletri T; Romeo F; Tucci P; Peschiaroli A; Annicchiarico-Petruzzelli M; Niklison-Chirou M; Amelio I; Knight R; Mak T; Melino G; Agostini M
Cell Cycle; 2015; 14(10):1611-2. PubMed ID: 25997017
[No Abstract] [Full Text] [Related]
33. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
[TBL] [Abstract][Full Text] [Related]
35. Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.
Shi D; Mu S; Pu F; Zhong B; Hu B; Muhtar M; Tong W; Shao Z; Zhang Z; Liu J
Cell Mol Life Sci; 2022 Jul; 79(8):427. PubMed ID: 35842562
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond.
Logotheti S; Richter C; Murr N; Spitschak A; Marquardt S; Pützer BM
Front Cell Dev Biol; 2021; 9():737735. PubMed ID: 34650986
[TBL] [Abstract][Full Text] [Related]
37. The comprehensive landscape of miR-34a in cancer research.
Li S; Wei X; He J; Cao Q; Du D; Zhan X; Zeng Y; Yuan S; Sun L
Cancer Metastasis Rev; 2021 Sep; 40(3):925-948. PubMed ID: 33959850
[TBL] [Abstract][Full Text] [Related]
38. Neural Networks Recapitulation by Cancer Cells Promotes Disease Progression: A Novel Role of p73 Isoforms in Cancer-Neuronal Crosstalk.
Logotheti S; Marquardt S; Richter C; Sophie Hain R; Murr N; Takan I; Pavlopoulou A; Pützer BM
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339112
[TBL] [Abstract][Full Text] [Related]
39. p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?
Wang C; Teo CR; Sabapathy K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079264
[TBL] [Abstract][Full Text] [Related]
40. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
